Oscar Health, Inc. (NYSE:OSCR) Receives $13.50 Average Price Target from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $15.00.

A number of research firms have issued reports on OSCR. TheStreet raised Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. Raymond James started coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. The Goldman Sachs Group boosted their price objective on shares of Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Wells Fargo & Company increased their target price on Oscar Health from $20.00 to $24.00 and gave the company an “overweight” rating in a research note on Thursday.

Oscar Health Stock Performance

NYSE OSCR opened at $22.17 on Tuesday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $5.09 billion, a PE ratio of -18.47 and a beta of 1.66. The business’s 50-day moving average price is $15.50 and its 200 day moving average price is $12.02. Oscar Health has a twelve month low of $4.72 and a twelve month high of $22.30.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. During the same quarter last year, the firm posted ($0.18) earnings per share. Oscar Health’s revenue was up 45.8% on a year-over-year basis. On average, research analysts predict that Oscar Health will post -0.23 earnings per share for the current year.

Institutional Trading of Oscar Health

Several hedge funds have recently made changes to their positions in OSCR. Precision Wealth Strategies LLC bought a new position in Oscar Health in the 3rd quarter worth about $60,000. SG Americas Securities LLC acquired a new position in shares of Oscar Health during the third quarter valued at $62,000. Avalon Trust Co bought a new stake in shares of Oscar Health during the first quarter valued at about $69,000. Brown Advisory Inc. acquired a new stake in Oscar Health in the third quarter worth about $83,000. Finally, Amalgamated Bank grew its position in Oscar Health by 10.6% in the 3rd quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock valued at $88,000 after buying an additional 1,516 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.